El tratamiento con quimioterapia hoy en pacientes HER2 negativo: el papel de la eribulina - page 33

Eribulin Mesilate: outline
Origins and Mechanisms of action
Classis Anti-mitotic efects
Non-mitotic Effects of Eribulin in the tumour biology
Clinical Development
Fase III trials
Pooled analysis
Real world evidence
Ongoing combination trials
1...,23,24,25,26,27,28,29,30,31,32 34,35,36,37,38,39,40,41,42,...43
Powered by FlippingBook